EPIDIOLEX (cannabidiol 100mg/mL oral solution) is one of the first medicinal cannabis pharmaceuticals to be trialled in Queensland specifically for children with treatment resistant epilepsy.
Researchers hope to begin recruitment of patients for the trial in Nov with a maximum of 30 children to be included.
Qualification criteria include being under the care of a paediatric neurologist as well as other stipulations around length of treatment and severity of disease.
Anyone who thinks they are eligible and is interested in participating in the trial can talk to their treating doctor or call 13HEALTH (13 43 25 84) to register an expression of interest.
Families will be advised if they meet the criteria and will be invited to take part in the trial.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Oct 16